...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >A Study On Lipid Profile, Oxidation Stress And Carbonic Anhydrase Activity In Patients With Essential Hypertension
【24h】

A Study On Lipid Profile, Oxidation Stress And Carbonic Anhydrase Activity In Patients With Essential Hypertension

机译:原发性高血压患者血脂谱,氧化应激和碳酸酐酶活性的研究

获取原文

摘要

BACKGROUND OF THE STUDY: The incidence of cardiovascular diseases (CVDs) is rising and they are predicted to be the biggest causes of death by 2020 in India. Various epidemiological studies have highlighted the increasing incidence of hypertension, which is assumed to be one of the major risk factors in CVD. Even though effective treatment measures have been extended against hypertension, it still remains inadequately managed. Increased levels of serum cholesterol, TG and VLDL have been observed in patients with hypertension. Considering the view points and the relationship between hypertension, lipid profile and carbonic anhydrase modulation in diuretic therapy and scanty literature reports in this region, the current study was focused to determine the association of lipid profile and carbonic anhydrase activity in essential hypertension patients. AIMS AND OBJECTIVES: The aim of the present study was to determine the serum lipid profile, malondialdehyde levels and carbonic anhydrase activity in known cases of essential hypertensive patients and to compare the results with age-sex matched healthy controls in our community. MATERIALS AND METHODS: One hundred fifty-six participants (107 males; 49 females) were enrolled for the present study, with their ages ranging from 32 to 66 years. Seventy hypertensive patients (42 men and 28 women, 32- 64 yrs of age) and 86 normotensive healthy controls (65 men and 21 women, 32-66 yrs of age) were recruited for the study. Patients with essential hypertension were included in the study. Smokers, obese subjects and patients on anti-hypertensive drugs for >3 months were excluded from the study. Also, patients on lipid lowering drugs and antioxidant vitamin supplements were also excluded. Lipid profile, malondialdehyde levels and carbonic anhydrase activity were analyzed by standard methods in both the groups of subjects. The data from the patients and controls were compared by the Student?s t-test. The values are expressed as mean ± standard deviation (SD). Microsoft Excel for Windows 2003 was used for statistical analysis. P-values <0.05 were considered to indicate statistical significance.RESULTS: The lipid profile variables were significantly higher when compared to the healthy controls. The differences were highly significant in total cholesterol and triglycerides, but were not significant in HDL-C, LDL-C and VLDL. The study also observed higher levels of malondialdehyde in hypertensive patients (p<0.005) as compared to the levels in the normotensive controls. The carbonic anhydrase activity in hypertensive patients was also observed to be highly significant (p<0.001) as compared to that in the healthy controls. CONCLUSION: The lipid profile is bound to be altered in essential hypertension cases, along with increased oxidative stress and is associated with an increased activity of carbonic anhydrase.
机译:研究背景:心血管疾病(CVD)的发病率正在上升,预计到2020年,它们将成为印度最大的死亡原因。各种流行病学研究都强调了高血压的发病率不断上升的趋势,认为高血压是CVD的主要危险因素之一。即使有效的治疗措施已经扩展到对抗高血压,但仍然没有得到足够的管理。在高血压患者中,血清胆固醇,TG和VLDL水平升高。考虑到利尿剂治疗中高血压的观点,高血压,脂质谱和碳酸酐酶调节之间的关系以及该地区的文献报道不足,本研究着重于确定原发性高血压患者的脂质谱和碳酸酐酶活性之间的关系。目的和目的:本研究的目的是确定已知高血压原发性病例的血清脂质谱,丙二醛水平和碳酸酐酶活性,并将结果与​​年龄相匹配的健康对照者进行比较。材料与方法:156名参与者(男107例;女49例)参加了本研究,年龄在32至66岁之间。该研究招募了70名高血压患者(42名男性和28名女性,年龄32-64岁)和86名血压正常的健康对照(65名男性和21名女性,年龄32-66岁)。患有原发性高血压的患者被纳入研究。该研究排除了吸烟者,肥胖受试者和服用抗高血压药物超过3个月的患者。此外,还排除了使用降脂药和抗氧化剂维生素补充剂的患者。通过标准方法在两组受试者中分析脂质分布,丙二醛水平和碳酸酐酶活性。通过Student's t检验比较了患者和对照组的数据。这些值表示为平均值±标准偏差(SD)。 Windows 2003的Microsoft Excel用于统计分析。 P值<0.05被认为具有统计学意义。结果:与健康对照组相比,脂质谱变量显着更高。差异在总胆固醇和甘油三酸酯中非常显着,但在HDL-C,LDL-C和VLDL中不显着。该研究还发现,与正常血压对照相比,高血压患者的丙二醛水平更高(p <0.005)。与健康对照相比,高血压患者的碳酸酐酶活性也被观察到非常显着(p <0.001)。结论:在原发性高血压病例中,脂质谱必将发生改变,同时氧化应激增加,并且与碳酸酐酶活性增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号